Rejected at 1:36 p.m. Jul, 26, 2025 ] by mohannadkh10
Author: hokonkwo
Related Note: 1472000196513
Rationale for change

its supposed to say increase ERP or atleast change it. Class 1 antiarrythmics are working on Fast Na channels which don't affect AV/SA node and SHOULD affect purkinje fibers and ventricular tissue

Rejection reason

Please resubmit with an acceptable rationale. Please review suggestion guidelines, specifically rule #2:

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#OME::PreClinical::Cardiac::Cardiac_5::Electricity::Arrhythmias #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#FirstAid::07_Cardiovascular::05_Pharm::11_Antiarrhythmics-sodium_channel_blockers_(class_I) #AK_Step1_v12::#SketchyPharm::02_Cardio_&_Renal::04_Antiarrhythmics::01_Class_I_A-C #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::17_Class_IA,_IB,_and_IC_Antiarrhythmics #AK_Step1_v12::#Pixorize::03_Pharmacology::21_Antiarrhythmics_(New)::05_Class_IC_Antiarrhythmics #AK_Step1_v12::#Bootcamp::Cardiology::13_Antiarrhythmics::02_Class_I_Antiarrhythmics #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::05_Antiarrhythmic_Drugs #AK_Step1_v12::^Systems::Cardio::Pharmacology